Belpointe Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-384
Closed -$9.95K 3081
2023
Q1
$9.95K Sell
384
-75
-16% -$2.01K ﹤0.01% 2722
2022
Q4
$10.9K Buy
+459
New +$12.4K ﹤0.01% 2572
2022
Q1
Sell
-1,940
Closed -$126K 1304
2021
Q4
$126K Buy
1,940
+49
+3% +$5.86K 0.01% 1098
2021
Q3
$167K Sell
1,891
-1,403
-43% -$204K 0.01% 935
2021
Q2
$548K Buy
3,294
+340
+12% +$55.1K 0.04% 470
2021
Q1
$536K Sell
2,954
-11,058
-79% -$2.56M 0.05% 409
2020
Q4
$2.8M Buy
14,012
+9,875
+239% +$2.01M 0.25% 83
2020
Q3
$907K Sell
4,137
-761
-16% -$161K 0.1% 224
2020
Q2
$934K Sell
4,898
-73
-1% -$12.8K 0.12% 183
2020
Q1
$771K Buy
4,971
+3,542
+248% +$412K 0.14% 176
2019
Q4
$120K Buy
+1,429
New +$109K 0.02% 714

Other funds holding TDOC

Belpointe Asset Management's TDOC Position: Q2 2023 in Review

Belpointe Asset Management sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 384 shares — an estimated $9.95K sold.

Belpointe Asset Management first reported a position in TDOC in Q4 2019 and held it in 11 quarters. The position peaked at $2.8M in Q4 2020. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Belpointe Asset Management reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 384 Teladoc Health shares in Q2 2023, an estimated $9.95K.
  • Belpointe Asset Management first reported a position in Teladoc Health in Q4 2019 and held it in 11 quarters.
  • Belpointe Asset Management's Teladoc Health position peaked at $2.8M in Q4 2020.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.